Original Articles Open access

High flow nasal cannula combined with non-invasive ventilation versus high flow nasal cannula alone in patients with acute hypoxemic respiratory failure due to pneumonia: a randomized controlled trial

Authors

Published
28 March 2023
Section
Original Articles
DOI
10.4081/ecj.2023.11088

Abstract

In this monocentric, open label, randomized controlled trial we aimed to compare the efficacy of combined High Flow Nasal Cannula (HFNC) and Non invasive Ventilation (NIV) versus HFNC alone in acute hypoxemic respiratory failure (hARF) in patients affected by Community Acquired Pneumonia (CAP). We enrolled 49 patients affected by CAP with moderate to severe hypoxemic respiratory failure (P/F < 300). The patients were randomized into two groups: one has been treated with HFNC alone (group A) while the other received NIV alternated to HFNC every 3 hours (group B). The primary outcome was P/F change from baseline to 21 hours. Secondary outcomes included variation of pH and pCO2, need to continue HFNC or NIV/HFNC after 45 hours, orotracheal intubation, mortality rate, and the devices comfort. Not statistical significant differences between the two arms were shown in the P/F change at 21 hours since baseline, in pCO2 and pH variation, mortality at hospital and at follow-up. We emphasize the importance of combined HFNC with NIV as a first step for severe pneumonia treatment whereas HFNC might represent as the first step treatment in less severe patients and during the NIV intervals.

Keywords

References

  1. Rochwerg B, Brochard L, Elliott MW, et al. Official ERS/ATS clinical practice guidelines: noninvasive ventilation for acute respiratory failure. Eur Respir J 2017;50:1602426. DOI: https://doi.org/10.1183/13993003.02426-2016
  2. Carrillo A, Gonzalez-Diaz G, Ferrer M, et al. Non-invasive ventilation in community-acquired pneumonia and severe acute respiratory failure. Intensive care Med 2012;38:458-66. DOI: https://doi.org/10.1007/s00134-012-2475-6
  3. Confalonieri M, Potena A, Carbone G, et al. Acute respiratory failure in patients with severe community-acquired pneumonia: a prospective randomized evaluation of noninvasive ventilation. Am J Respir Crit Care Med 1999;160:1585-91. DOI: https://doi.org/10.1164/ajrccm.160.5.9903015
  4. Holleman-Duray D, Kaupie D, Weiss MG. Heated humidified high-flow nasal cannula: use and a neonatal early extubation protocol. J Perinatol 2007;27:776–81. DOI: https://doi.org/10.1038/sj.jp.7211825
  5. Spentzas T, Minarik M, Patters AB et al. Children with respiratory distress treated with high-flow nasal cannula. J Intensive Care Med 2009;24:323–28. DOI: https://doi.org/10.1177/0885066609340622
  6. Drake MG. High-flow nasal cannula oxygen in adults: an evidence-based assessment. Ann Am Thorac Soc 2008;15:145-55. DOI: https://doi.org/10.1513/AnnalsATS.201707-548FR
  7. Bottani G, Centurioni, F, Veronese G, et al. Current application of high flow oxygen nasal cannula in acute hypoxemic respiratory failure in the emergency department. Emerg Care J 2018;13:7036. DOI: https://doi.org/10.4081/ecj.2017.7036
  8. Nishimura M. High-flow nasal cannula oxygen therapy in adults: physiological benefits, indication, clinical benefits, and adverse effects. Respir Care 2016;61:529-41. DOI: https://doi.org/10.4187/respcare.04577
  9. Parke, RL. Pressures delivered by nasal high flow oxygen during all phases of the respiratory cycle. Respir Care 2013;10:1621-24. DOI: https://doi.org/10.4187/respcare.02358
  10. Corley A, Caruana LR, Barnett AG, et al. Oxygen delivery through high-flow nasal cannulae increase end-expiratory lung volume and reduce respiratory rate in post-cardiac surgical patients. Br J Anaesth 2011;107:998-1004. DOI: https://doi.org/10.1093/bja/aer265
  11. Nuttapol R, Tscheikuna J, Praphruetkit N, Kijpinyochai S. Use of high-flow nasal cannula for acute dyspnea and hypoxemia in the emergency department. Resp Care 2015;60:1377-82. DOI: https://doi.org/10.4187/respcare.03837
  12. Nava S, Hill N. Non-invasive ventilation in acute respiratory failure. Lancet 2009;374:250-59. DOI: https://doi.org/10.1016/S0140-6736(09)60496-7
  13. Lari F, Scandellari N, De Maria, et al. Non-invasive mechanic ventilation in treating acute respiratory failure. Emerg Care J 2009;5:8-20. DOI: https://doi.org/10.4081/ecj.2009.6.8
  14. Carron M, Freo U, Zorzi M, Ori C. Predictors of failure of noninvasive ventilation in patients with severe community-acquired pneumonia. J Crit Care 2010;25:540-e9-14. DOI: https://doi.org/10.1016/j.jcrc.2010.02.012
  15. Grieco D L, Maggiore S M, Roca O, et al. Non-invasive ventilatory support and high-flow nasal oxygen as first-line treatment of acute hypoxemic respiratory failure and ARDS. Intensive Care Med 2021;47:851-66. DOI: https://doi.org/10.1007/s00134-021-06459-2
  16. Ricard JC. High flow nasal oxygen in acute respiratory failure. Minerva Anestesiol 2012;78:836-41.
  17. Greene KE, Peters JL. Pathophysiology of acute respiratory failure. Clinics Chest Med 1994;15:1-12. DOI: https://doi.org/10.1016/S0272-5231(21)01052-2
  18. Parke R, McGuinnes S, Eccleston M. Nasal high-flow therapy delivers low level positive airway pressure. Br J Anaesth 2009;103:886-90. DOI: https://doi.org/10.1093/bja/aep280
  19. Ritchie J E, Williams A B, Gerard C, Hockey H. Evaluation of a humidified nasal high-flow oxygen system, using oxygraphy, capnography and measurement of upper airway pressures. Anaesth Intensive Care 2011;39:1103-10 DOI: https://doi.org/10.1177/0310057X1103900620
  20. Paolini V, Faverio P, Aliberti S, et al. Positive end expiratory pressure in acute hypoxemic respiratory failure due to community acquired pneumonia: do we need a personalized approach? Peer J 2018;30;6:e4211 DOI: https://doi.org/10.7717/peerj.4211
  21. MacIntyre, Neil R. Physiologic effects of noninvasive ventilation. Respir Care 2019;64:617-28. DOI: https://doi.org/10.4187/respcare.06635
  22. Frat JP, Thille AW, Mercat A, et al. High-flow oxygen through nasal cannula in acute hypoxemic respiratory failure. N Engl J Med 2015;372:2185-96. DOI: https://doi.org/10.1056/NEJMoa1503326

Metrics

Citations and online attention from Dimensions, Altmetric and PlumX.

PlumX Metrics

License

Copyright (c) 2023 the Author(s)

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.